Continuum Advisory’s BioLife Solutions BLFS Stock Holding History

Continuum Advisory’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-29	Closed	-$628	–	1867
2024 Q3	$628	Buy	+29	New	+$685	﹤0.01%	1736

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Continuum Advisory's BLFS Position: Q4 2024 in Review

Continuum Advisory sold out of BioLife Solutions (BLFS) in Q4 2024, closing a stake of 29 shares — an estimated $628 sold.

Continuum Advisory first reported a position in BLFS in Q3 2024 and held it in 1 quarter. The position peaked at $628 in Q3 2024. 180 funds tracked by Wall St. Rank hold BLFS as of Q4 2024.

Continuum Advisory reported no remaining BioLife Solutions position as of Q4 2024 after selling out during the quarter.
Continuum Advisory sold 29 BioLife Solutions shares in Q4 2024, an estimated $628.
Continuum Advisory first reported a position in BioLife Solutions in Q3 2024 and held it in 1 quarter.
Continuum Advisory's BioLife Solutions position peaked at $628 in Q3 2024.
180 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2024.

Based on Continuum Advisory's 13F filing for Q4 2024, filed 18 Feb 2025.